Life YES, Diabetes NO! Reversing the diabetes epidemic in the high risk, underserved Latino community​

June 10, 2017




Josephine  Guzman, Sr. Director Physician Relations at Lenox Hill Hospital, located on Manhattan’s Upper East Side with a national reputation for outstanding patient care and innovative medical and surgical treatments joins eHealth Radio and the Diabetes, Health Care and Health News Channels to discuss their Diabetes Inititative within the Lation community.


Listen to interview with host Eric Michaels & guest Josephine  Guzman discuss the following:

  • In addition to your role as Sr. Director, Physician Recruitment at Lenox Hill Hospital in New York, you act as Multicultural or Latino patient champion and are spearheading a population management initiative called Life YES, Diabetes NO!  Tell us about that.
  • Why is a campaign to educate and fight diabetes in the Latino Community important?
  • What is unique about this campaign?
  • What are some actions you are taking through this campaign?
  • How will you measure the success?


As Sr. Director of Physician Relations, Josie Guzman plays a critical role in attracting new physician talent to the institution and is the facilitator of information and resources between Northwell Health Lenox Hill Hospital, the internal medical team and the affiliated physicians located throughout the New York metropolitan area, ensuring that these physicians provide the highest quality care possible to their patients regardless of their location or ethnic or economic background.  Josie’s business successes have been coupled with many personal successes including her deep commitment to the community in which she lives. She lives in the same neighborhood of her youth and is satisfied to know she has opened doors for others of her gender and nationality.

You can follow the campaign and get updates on “¡Vida SI, Diabetes NO!” (Life YES, Diabetes NO!) on social media including Facebook, also on Twitter @VidaSIDiabetesNO and on Instagram under user name @vsidno.



The Father of Natural Health Discovers the Solution to Reverse the Trend of Chronic Conditions

May 22, 2017


Dr. Joseph Pizzorno, the author of the new book called, The Toxin Solution, How Hidden Poisons in the Air, Water, Food, and Products We Use Are Destroying Our Health-And What We Can Do To Fix It joins eHealth Radio and the Health News & Nutrition Channels.

Listen to interview with host Eric Michaels and guest Dr. Joseph Pizzorno discuss the following:

  • Can you frame-up the Health Problem, as you see it, that most of us are faced with today and give us some statistics to provide us with a reference point to the past?
  • Tell us what led you to start researching in the area of toxins and some commonalities that you started to see in your practice that led you into this area.
  • So these aren't what most people think in terms of toxins. Are these everyday exposures that are creating the issue?
  • What are some of the most common conditions that you've concluded are a result of this overload of toxins, and what are some of the reversals that you've witnessed by following the right protocol.
  • You've provided a great program for someone to follow in your book, are there other resources that can help someone?

Dr. Joseph E. Pizzorno, Jr., is the current President of Salugenecists, Inc. and is the current Chief Medical Director for Village Green Apothecary and iThrivePH.

Dr. Pizzorno is one of the world's leading authorities on science-based natural medicine. Dr. Pizzorno, is the founding president of Bastyr University, which became the first fully accredited, multidisciplinary university of natural medicine. He's a best-selling author of The Encyclopedia of Natural Medicine, selling over 2.5M copies around the world. His recent accomplishments include the creation of a science-based, on-line smart tool for health, called IQYOU. By integrating over 30,000 medical studies, 6,000 prescription data, lifestyle data, government toxin data, DNA data, over 300 lab tests, it's the first tool of it's kind to provide real wellness solutions to the masses. This health tool provides a quick risk assessment for consumers and the research and quick recommendations to maximize their health potential: .

Dr. Pizzorno's ground-breaking book, The Toxin Solution, is being revered by leaders in the health community as a must-read for anyone focuses on their health, and one of the most significant books on health this century. His easy-to-follow process will help millions of people to take back their health and to reverse conditions that they once thought were irreparable. The Toxin Solution has been integrated into IQYOU to provide a personalized approach to an individuals health.


Website: |

Rapid growth, dynamic and effective product line, thriving as a small cap company in a difficult environment

April 13, 2017




Todd Davis, the CEO & Founder of Endexx Corporation, a diversified company with two key operating entities (M3Hub/Autospense Technologies & CBD Unlimited-Hemp Nutraceuticals joins eHealth Radio and the Diabetes, Health News & Nutrition & Pain Management Channels. Todd has 26 years experience in the Investment Banking and Small Cap Markets.


Listen to interview with host Eric Michaels and guest Todd Davis discuss the following:

  • Why are phytocannabinoids so important for quality wellness?
  • What methods and testing are you using with CBD?
  • How are your products helping People and Pets?
  • How well are your products performing in the market?
  • On the side, how are your developments with Autospense Progressing?
  • Are you uplisting and completing your Audit?


Todd Davis is Chairman and CEO of Endexx Corporation and has been since 2003. Todd was an Investment Banker/Stockbroker, and trading analyst from1990-2000. He also serves and has served as CEO/President/CFO/COB and Director in multiple publicly traded companies from 2001-2016 (present).

Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full

Endexx accountability through "seed to sale" inventory management and an "End of Sale" technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.


Screen_Shot_2016-11-01_at_6_16_31_PM.png |

21 Things You Need to Know About Diabetes & Weight Loss Surgery

March 3, 2017



Dr. Scott Cunneen, Director of Metabolic and Bariatric Surgery at Cedars-Sinai Medical Center in Los Angeles, and author of a new book just published by the American Diabetes Association called 21 Things You Need to Know About Diabetes & Weight Loss Surgery again joins eHealth Radio and the Diabetes & Weight Management Channels.


Listen to interview with host Eric Michaels and guest Dr. Scott Cunneen discuss the following:

  • We talked with you a few years ago when your first book on weight loss surgery was published.  What’s different in this new book?
  • So does weight loss surgery actually provide a cure for diabetes?
  • With more than 200,000 weight loss surgical procedures performed every year in this country, wouldn’t you think the number of people with diabetes would be going down instead of up?
  • Which weight loss procedures work the best on diabetes?
  • How would you suggest people start finding out if weight loss surgery is right for them, whether or not they have diabetes?


Scott A. Cunneen, MD, FACS, FASMBS, is Director of Metabolic and Bariatric Surgery at Cedars-Sinai Medical Center in Los Angeles.  A graduate of the University of Notre Dame, he hold a master's degree in physiology from Georgetown University and a master's degree in human nutrition from the Columbia University College of Physicians and Surgeons. He earned his medical degree from Georgetown University. 




A Fellow of the American Society of Metabolic & Bariatric Surgeons, Dr. Cunneen also serves on the editorial advisory board of and, and is often called upon to teach laparoscopic procedures throughout the U.S. and abroad. He is the author of 21 Things You Need to Know About Diabetes & Weight Loss Surgery, published by the American Diabetes Association.

Sugar’s impact on our health with Keren Slutzkin

January 4, 2017



Keren Slutzkin, Founder of Vital Assurance joins eHealth Radio and the Nutrition & Health News Channels. Keren is a certified Health and Wellness coach, article writer, recipe developer and cooking demonstrator who specialises in inspiring other mums to live healthier, happier lives.


Listen to interview with host Eric Michaels & guest Keren Slutzkin discuss the following:

  • Keren, can you please tell us a little about yourself and your own health journey?
  • What are the positive implications you have seen within yourself and your family after making these changes?
  • It is becoming apparent that there is a health epidemic in relation to obesity and diabetes.  What is your understanding of what could be contributing to this?
  • What is your biggest concern in regards to the world's current sugar consumption?
  • What are some signs that someone may be a sugar addict?
  • If you are telling people to reduce the amount of carbohydrates that they are consuming, then what food options are left for them to eat?
  • What are some tips that you could provide our listeners with if they were considering to reduce their sugar consumption.


Keren Slutzkin is a mum of 2 young boys and the founder of Vital Assurance.  She is a holistic Health and Wellness coach, health article writer, recipe developer and cooking demonstrator that specialises in inspiring other mums and their families to live healthier, happier lives.  
Her passion is coaching mums that are overwhelmed with conflicting information around health, that don't enjoy being in the kitchen cooking, and need some additional guidance in making better decisions around their health and food choices. She is really passionate about food, and enjoy creating and sharing nutritious, budget friendly meals for everyone to enjoy. 





Social Media Links:

For a complimentary 30 minute consultation, contact Keren at

New Pre-Meal Drink Offering Hope for those with Type 2 Diabetes

November 20, 2016



Arie Nudel, the Managing Director of Omni Innovation, which specialises in medical nutrition joins eHealth Radio and the Diabetes and Health News Channels.

Omni Innovation makes a unique pre-meal drink for people with Type 2 diabetes that reduces the Glyceamic Index (GI) of your food and drink and controls the spikes in blood glucose which, over time, can cause serious damage.

Listen to interview with host Eric Michaels and guest Arie Nudel discuss the following:

  • What is Omni Innovation and GlucoControl?
  • Why did you decide to try and make a product for those with type 2 diabetes?
  • What can GlucoControl do to help those with Type 2 diabetes?
  • Why hasn’t something like this been developed before?
  • What is the scope for wider distribution of this product? Does it have global appeal?

Duration: 11:14

Omniblend Innovation creates unique and specialised food grade products that can be used by people with diabetes and other health conditions. Clinical validation of our products is supervised by our expert collaborator network to ensure that our customers have safe, effective and clinically tested products.

Our flagship product, GlucoControl, is a patented pre-meal drink that smooths out the blood glucose spike after a meal for people with type 2 diabetes and pre-diabetes.

Type 2 diabetes is one of Australia’s most prevalent and fast growing chronic diseases. More than 200 Australian’s develop the condition every day.

Over 1 million Australians currently have type 2 diabetes and an additional 1.5 million have pre-diabetes. Globally over 380 million people have type 2 diabetes – this does not count people with pre-diabetes. China alone has more than 200 million people with diabetes or pre-diabetes.

Clinical testing and validation of GlucoControl was conducted at The Baker IDI Heart and Diabetes Institute in Melbourne, Australia under the supervision of Professor Peter Clifton. Peter is the co-author of the successful CSIRO Total Health and Well-being Diet.



Phyto Nutrients for Health: The next big Oil Boom.

November 1, 2016

Todd Davis, the CEO & Founder of Endexx Corporation, a diversified company with two key operating entities (M3Hub/Autospense Technologies & CBD Unlimited-Hemp Nutraceuticals joins eHealth Radio and the Health News & Nutrition Channels. Todd has 26 years experience in the Investment Banking and Small Cap Markets.

Listen to interview with host Eric Michaels and guest Todd Davis discuss the following:

  • What's your background and how did you get into the CBD Industry?
  • What research or testing have you done with your products?
  • How do the products help people, how do they help pets?
  • What kind of feedback do you get from your customers?

Todd Davis is Chairman and CEO of Endexx Corporation and has been since 2003. Todd was an Investment Banker/Stockbroker, and trading analyst from1990-2000. He also serves and has served as CEO/President/CFO/COB and Director in multiple publicly traded companies from 2001-2016 (present). | |

The 9 Carbs to Avoid for a Healthy Life

March 25, 2016

Dr. Bruce Roseman the author of book "The Addictocarb Diet:  Avoid the 9 Highly Addictive Carbs while Eating Anything Else You Want" joins eHealth Radio and the Diabetes, and Health News Channels. Dr. Roseman is a family doctor in practice in Manhattan for over 30 years affiliated with Mount Sinai Hospital.

Listen to interview with host Eric Michaels and guest Dr. Bruce Roseman discuss the following:

  • Why are certain carbs so dangerous?

  • Why did you write “The Addictocarb Diet?”

  • What are the steps to take to eliminate a carb addiction?
  • It seems simple, but why can’t people shake the addiction?
  • Why does your diet, as opposed to Weight Watchers, work?
  • Does your diet prohibit chocolate?

  • What foods do you recommend that listeners eliminate as everyone thinks about weight loss and resolutions to live healthier?

Duration: 32:26

Dr. Bruce Roseman has been a Family Doctor in private practice in Manhattan for 30 years, and is affiliated with Mount Sinai Hospital where he holds joint appointments in the departments of Family Medicine and Ob/Gyn.

He has served as medical editor for several food/health-related books and magazines including The Olive Oil Cookbook, The Low Cholesterol Oat Cure, Whittle’s The Health Report, Big Bird Goes to the Doctor (Sesame Street), and as a medical columnist for Woman’s World.

Dr. Roseman has appeared on numerous television and radio programs as a medical expert, including Live Wire (PBS), The Human Condition (NPR) Good Day New York, The Queen Latifah Show, and The Joan Lunden Show, and has been featured in magazines such as Guideposts and Parent.

He is also the author of A Kid Just Like Me (Penguin/Putnam, 2001), which details a popular method he invented to teach children with learning disabilities to read, while working with his son.

Dr. Roseman lives happily, in New York City, with his wife of over a quarter century, Ellen, and is proud to be the father of two fine young men, Joshua and Aaron.


Managing Diabetes in the Digital World – Introducing the DARIO

September 9, 2015

Todd Durniak, Executive VP of US Operations at  Labstyle Innovations that powers the DARIO, a unique diabetes management platform that allows patients and doctors seamlessly manage their condition joins eHealth Radio and the Diabetes, Health News & Technology Channels.

Listen to interview with host Eric Michaels and guest Todd Durniak discuss the following:

  • For those living with diabetes, what would you say is the major challenge in managing this condition today?
  • How can your platform technology, Dario™ Diabetes Management Solution address this challenge? Can you explain how it works with smart devices such as phones and ipads? 
  • There’s a lot of technology out there to help People with Diabetes manage their disease.  How is DARIO different?
  • Aside from the DARIO user, who else can access remotely the blood sugar meter readings? Why is this information important?  
  • Labstyle Innovations has an online Facebook community called the DARIO Lounge. Why are these community groups so important in helping patients stay compliant and healthy? 
  • The DARIO platform also includes a suite of apps for the smartphone -- How do they work in the overall success for diabetic patients? Would the apps be available for non-diabetic patients?
  • Can you share where the DARIO is currently available and when will be available for US patients?

Duration: 9:26

Todd Durniak is Labstyle Innovations’s Senior Vice President and General Manager for the U.S.  Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach. 

Prior to Insulet and Neighborhood Diabetes, Durniak held a number of positions of increasing responsibility over 7 years at Smith & Nephew Orthopedics, most recently as President, Asia Pacific, based in Sydney, Australia. 

Durniak began his career in engineering with Johnson & Johnson Orthopedics, leaving to start and manage Texas Direct Medical, an orthopedic product distributorship.  He later re-joined Johnson & Johnson post the acquisition of DePuy, moving through a series of positions before joining Guidant just prior to its acquisition by Boston Scientific.

Durniak holds a BS of Engineering in Biomedical Engineering from the University of Vermont and an MBA from Boston University.


Oral Insulin and Diabetes: How Close are we to this Medical Breakthrough?

August 5, 2015

Josh Hexter, Chief Operating Officer of Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems including what would be the first oral formulation of insulin joins eHealth Radio and the Diabetes, Pharmaceutical, & Health News Channels.

Listen to interview with host Eric Michaels and guest Josh Hexter discuss the following:

  • Many listeners may be familiar with diabetes, either they are affected or know a family member affected by the condition. Can you explain to our listeners the differences between the Type I and II diabetes? What toll does this disease create?
  • What role does insulin play in diabetes? 
  • Why has it taken so long for researchers to turn insulin into a pill? What has been the challenges? 
  • Your company is working on an oral version of insulin. Can you describe how does it work and what stage are you in drug’s development? 
  • Can you explain why treating patients who may be at risk for Type II diabetes (prediabetes) with Oramed’s oral pill? What protection does the oral version of insulin provide?

Duration: 14:35

Mr. Hexter serves as Chief Operating Officer and Vice President of Business Development of Oramed Pharmaceuticals, which he joined in 2013. He brings to Oramed more than 15 years of prominent leadership, business development, operations know-how and management in the life science sector. He was most recently Executive Director of Corporate In-Licensing at BioLineRx Prior to joining BioLineRx, he worked in private equity and venture capital where he served as CEO of a VC-backed startup.

As CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging business development agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security. Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.